Classical HSP90 inhibitors, i.e., GA-derivatives 17-AAG or EC5, were reported to significantly block human NB growth and induce apoptosis in vivo, by decreasing Raf-1 and increasing the expression of cleaved PARP [40]. Here, HSP90AB1 is linked to neuroblastoma.